Cytopoint (Locivetmab) in Dogs
Generic: Locivetmab
Cytopoint (Lokivetmab) is an injectable monoclonal antibody therapy specifically designed to reduce clinical signs of atopic dermatitis in dogs by targeting and neutralizing interleukin-31, a key protein involved in the itch pathway.
This medication is intended for dogs.
Overview
Cytopoint, generically known as Lokivetmab (Cytopoint), represents a breakthrough in veterinary dermatology as a biological therapeutic rather than a traditional chemical pharmaceutical. It is used primarily for the management of clinical signs associated with atopic dermatitis, a chronic condition causing significant skin irritation and pruritus in canine patients. Unlike systemic steroids or immunosuppressants, this injectable treatment focuses on the specific molecular signaling pathway responsible for the sensation of itching in dogs. Because it is highly specific, it does not broadly suppress the immune system, making it a favorable option for long-term management.
In clinical practice, this medication is frequently used in conjunction with topical treatments to manage secondary infections or skin barrier health. For instance, while managing the inflammatory component of the skin disease, veterinarians may concurrently use Douxo Chlorhexidine to control surface bacterial or fungal overgrowth. By effectively neutralizing the itch-causing protein in the body, it allows for better healing of the skin barrier, which might otherwise be compromised by constant scratching, licking, or biting by the dog. This dual-action approach often produces superior comfort levels compared to monotherapy in complex cases.
Furthermore, the targeted nature of this biologic therapy allows it to be used alongside other therapeutic modalities with minimal risk of interference. Whether a dog requires concurrent topical treatment with Hydrocortisone Topical for localized inflammation or specialized shampoos like Benzoyl Peroxide Shampoo to deep-cleanse infected hair follicles, the systemic action of the monoclonal antibody remains focused on the itch signaling pathway. Its predictable, sustained release profile ensures that pet owners do not have to struggle with the daily administration of oral pills, which is a common hurdle in the management of chronic atopic disease.
What It Treats
- Atopic Dermatitis: Used to manage the associated pruritus (itch) and inflammation in allergic dogs.
- Allergic Dermatitis: Helps reduce the clinical signs of skin irritation resulting from environmental allergies (e.g., pollen, dust mites).
- Chronic Pruritus: Provides relief from persistent itching that negatively impacts a dog's quality of life.
How It Works
Cytopoint is a monoclonal antibody that targets and neutralizes canine interleukin-31 (IL-31), which is a key cytokine—a signaling protein—that transmits the 'itch' signal to the brain. By binding to IL-31 in the bloodstream, the medication effectively acts like a roadblock, preventing the cytokine from reaching the receptors on the nerves that signal the sensation of itching. Because this mechanism is highly targeted at a specific itch pathway, it spares the rest of the immune system from general suppression. This 'lock-and-key' approach provides rapid relief from scratching, licking, and chewing, often within 24 hours of administration, and typically lasts for four to eight weeks, depending on the individual patient's severity and response.
Dosage
The dosage of Cytopoint is determined by the patient's weight, typically administered at a minimum dose of 2 mg/kg. It is essential to strictly follow your veterinarian’s instructions, as the frequency of injections—usually once every four to eight weeks—is tailored to the specific needs and clinical improvement of your dog.
Administration
Cytopoint is administered exclusively as a subcutaneous (under the skin) injection by a licensed veterinarian or authorized veterinary staff. Because it is a biological product, it requires precise handling and must not be shaken; it is injected into the subcutaneous space, typically between the shoulder blades or in the flank area, to ensure proper absorption.
Storage
Cytopoint must be stored in a refrigerator at a temperature between 2°C and 8°C (36°F to 46°F). The medication must be kept in the original carton to protect it from light and should never be frozen, as freezing can denature the protein structure and render the medication ineffective.
Contraindications
Cytopoint should not be used in dogs with a known hypersensitivity to the drug or its components. While the medication has a high safety profile, it is not intended for use in dogs younger than 3 months of age, as the safety and efficacy have not been established in these younger, developing immune systems. Furthermore, while it is not traditionally contraindicated in dogs with concurrent conditions, owners should always inform their veterinarian of any underlying health status. In cases of severe, deep-seated skin infections or systemic illnesses, the veterinarian will determine if the patient is stable enough to receive this therapy or if prior treatment of secondary bacterial or fungal infections is required.
Interactions
One of the major clinical advantages of this monoclonal antibody is that it has not shown significant drug-to-drug interactions in standard veterinary clinical studies. Because it is a protein-based therapy that works on a specific pathway, it does not interfere with the metabolism of common drugs such as antibiotics, antifungals, or anti-inflammatory medications. Consequently, it can be safely administered alongside standard medications like [Gentamicin Topical](/medications/gentamicin-topical-in-dogs-and-cats) or [Clotrimazole Topical](/medications/clotrimazole-topical-in-dogs-and-cats) without dose adjustments. However, it is always professional practice to maintain an updated list of all medications, supplements, and topicals your dog is currently receiving to ensure comprehensive dermatological health management.
Side Effects
- Vomiting
- Diarrhea
- Lethargy
- Injection site reaction (mild swelling or tenderness)
- Dermatitis or skin lesions
- Rare hypersensitivity reactions (anaphylaxis)
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.